Cargando…
Improving accuracy of breast cancer biomarker testing in India
There is a global mandate even in countries with low resources to improve the accuracy of testing biomarkers in breast cancer viz. oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2neu) given their critical impact in the management of patients. The...
Autor principal: | Shet, Tanuja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819026/ https://www.ncbi.nlm.nih.gov/pubmed/29434058 http://dx.doi.org/10.4103/ijmr.IJMR_896_16 |
Ejemplares similares
-
Breast cancer: An overview of published Indian data
por: Rangarajan, Bharath, et al.
Publicado: (2016) -
Merits of Level III Axillary Dissection in Node-Positive Breast Cancer: A Prospective, Single-Institution Study From India
por: Joshi, Shalaka, et al.
Publicado: (2019) -
Impact of COVID-19 on quality checks of solid tumor molecular diagnostic testing-A surveillance by EQAS provider in India
por: Shetty, Omshree, et al.
Publicado: (2022) -
Imaging of the treated breast post breast conservation surgery/oncoplasty: Pictorial review
por: Ramani, Subhash K, et al.
Publicado: (2017) -
Hyperechoic Lesions on Breast Ultrasound: All Things Bright and Beautiful?
por: Ramani, S. K., et al.
Publicado: (2021)